Real-time enrollment status for this hereditary hemorrhagic telangiectasia (hht) clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 6:26 PM UTC
| NCT Number | NCT07667413 |
| Recruiting Status | Recruiting |
| Condition | Hereditary Hemorrhagic Telangiectasia (HHT) |
| Phase | PHASE1 |
| Target Enrollment | 27 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Columbia University |
| Last Updated on CT.gov | June 25, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT07667413 is currently recruiting participants. This phase1 study for hereditary hemorrhagic telangiectasia (hht) is actively seeking new participants at 1 location across the United States. The study is sponsored by Columbia University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07667413 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07667413 was last updated 3 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.